Neutralizing antibodies mediate virus-immune pathology of COVID-19

SARS-CoV-2 is a novel beta-coronavirus causing over 200.000 lethal cases within six months of first infecting humans. SARS-CoV-2 causes COVID-19, a form of severe acute respiratory syndrome (SARS). COVID-19 is characterized by two phases: the first resembles the flu with pneumonia, but after about s...

Descripción completa

Detalles Bibliográficos
Autor principal: Jacobs, J.J.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832094/
https://www.ncbi.nlm.nih.gov/pubmed/32512289
http://dx.doi.org/10.1016/j.mehy.2020.109884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832094/
https://www.ncbi.nlm.nih.gov/pubmed/32512289
http://dx.doi.org/10.1016/j.mehy.2020.109884

Ejemplares similares